{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T07:37:01Z","timestamp":1791013021823,"version":"4.1.0"},"reference-count":117,"publisher":"American Society for Microbiology","issue":"2","license":[{"start":{"date-parts":[[2001,4,1]],"date-time":"2001-04-01T00:00:00Z","timestamp":986083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Clin Microbiol Rev"],"published-print":{"date-parts":[[2001,4]]},"abstract":"<jats:sec>\n                    <jats:title>SUMMARY<\/jats:title>\n                    <jats:p>Poxviruses continue to pose a major threat to human health. Monkeypox is endemic in central Africa, and the discontinuation of the vaccination (with vaccinia virus) has rendered most humans vulnerable to variola virus, the etiologic agent of smallpox, should this virus be used in biological warfare or terrorism. However, a large variety of compounds have been described that are potent inhibitors of vaccinia virus replication and could be expected to be active against other poxviruses as well. These compounds could be grouped in different classes: (i) IMP dehydrogenase inhibitors (e.g., EICAR); (ii) SAH hydrolase inhibitors (e.g., 5\u2032-noraristeromycin, 3-deazaneplanocin A, and various neplanocin A derivatives); (iii) OMP decarboxylase inhibitors (e.g., pyrazofurin) and CTP synthetase inhibitors (e.g., cyclopentenyl cytosine); (iv) thymidylate synthase inhibitors (e.g., 5-substituted 2\u2032-deoxyuridines); (v) nucleoside analogues that are targeted at viral DNA synthesis (e.g., Ara-A); (vi) acyclic nucleoside phosphonates [e.g., (S)-HPMPA and (S)-HPMPC (cidofovir)]; and (vii) polyanionic substances (e.g., polyacrylic acid). All these compounds could be considered potential candidate drugs for the therapy and prophylaxis of poxvirus infections at large. Some of these compounds, in particular polyacrylic acid and cidofovir, were found to generate, on single-dose administration, a long-lasting protective efficacy against vaccinia virus infection in vivo. Cidofovir, which has been approved for the treatment of cytomegalovirus retinitis in immunocompromised patients, was also found to protect mice, again when given as a single dose, against a lethal aerosolized or intranasal cowpox virus challenge. In a biological warfare scenario, it would be advantageous to be able to use a single treatment for an individual exposed to an aerosolized poxvirus. Cidofovir thus holds great promise for treating human smallpox, monkeypox, and other poxvirus infections. Anecdotal experience points to the efficacy of cidofovir in the treatment of the poxvirus infections molluscum contagiosum and orf (ecthyma contagiosum) in immunosuppressed patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1128\/cmr.14.2.382-397.2001","type":"journal-article","created":{"date-parts":[[2002,7,27]],"date-time":"2002-07-27T05:55:30Z","timestamp":1027749330000},"page":"382-397","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":145,"title":["Vaccinia Virus Inhibitors as a Paradigm for the Chemotherapy of Poxvirus Infections"],"prefix":"10.1128","volume":"14","author":[{"given":"Erik","family":"De Clercq","sequence":"first","affiliation":[{"name":"<!--label omitted: 1-->Division of Virology and Chemotherapy, Department of Microbiology and Immunology, Rega Institute for Medical Research, K.U. Leuven, B-3000 Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.85.16.6132"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.32.11.1742"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1042\/bj2870785"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(19)74507-4"},{"key":"e_1_3_2_6_2","first-page":"105","article-title":"The antiviral and synergistic actions of isathin thiosemicarbazone and certain phenoxypyrimidines in vaccinia infection in mice.","volume":"36","author":"Bauer D. J.","year":"1955","unstructured":"Bauer D. J. The antiviral and synergistic actions of isathin thiosemicarbazone and certain phenoxypyrimidines in vaccinia infection in mice. Br. J. Exp. Pathol. 36 1955 105 114","journal-title":"Br. J. Exp. Pathol."},{"key":"e_1_3_2_7_2","first-page":"1","article-title":"Introduction to antiviral chemotherapy","volume":"1","author":"Bauer D. J.","year":"1972","unstructured":"Bauer D. J. Introduction to antiviral chemotherapy International encyclopedia of pharmacology and therapeutics 1. Chemotherapy of viral diseases 1972 1 33 Pergamon Press Ltd. Oxford, United Kingdom","journal-title":"International encyclopedia of pharmacology and therapeutics"},{"key":"e_1_3_2_8_2","first-page":"35","article-title":"Thiosemicarbazones","volume":"1","author":"Bauer D. J.","year":"1972","unstructured":"Bauer D. J. Thiosemicarbazones International encyclopedia of pharmacology and therapeutics 1. Chemotherapy of viral diseases 1972 35 113 Pergamon Press Ltd. Oxford, United Kingdom","journal-title":"International encyclopedia of pharmacology and therapeutics"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(63)90230-7"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.38.10.2387"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm00178a001"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(17)43053-5"},{"key":"e_1_3_2_13_2","unstructured":"Boyle J. J. Haff R. F. Stewart R. C. Evaluation of antiviral compounds by suppression of tail lesions in vaccinia-infected mice 1967 536 539 Antimicrob. Agents Chemother. 1966."},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1086\/315190"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199808203390811"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm00075a030"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1135\/cccc19920661"},{"key":"e_1_3_2_18_2","first-page":"1502","article-title":"Identification of enzymes catalyzing two-step phosphorylation of cidofovir and the effect of cytomegalovirus infection on their activities in host cells.","volume":"50","author":"Cihlar T.","year":"1996","unstructured":"Cihlar T. Chen M. S. Identification of enzymes catalyzing two-step phosphorylation of cidofovir and the effect of cytomegalovirus infection on their activities in host cells. Mol. Pharmacol. 50 1996 1502 1510","journal-title":"Mol. Pharmacol."},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(89)90249-9"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(90)90720-6"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(90)90665-8"},{"key":"e_1_3_2_22_2","first-page":"718","article-title":"Mechanism of antiviral and cytotoxic action of (\u00b1)-6\u2032 \u03b2-fluoroaristeromycin, a potent inhibitor of S-adenosylhomocysteine hydrolase.","volume":"39","author":"Cools M.","year":"1991","unstructured":"Cools M. Balzarini J. De Clercq E. Mechanism of antiviral and cytotoxic action of (\u00b1)-6\u2032 \u03b2-fluoroaristeromycin, a potent inhibitor of S-adenosylhomocysteine hydrolase. Mol. Pharmacol. 39 1991 718 724","journal-title":"Mol. Pharmacol."},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(99)01782-1"},{"key":"e_1_3_2_24_2","first-page":"253","article-title":"Antiviral and antitumor activities of 5-substituted 2\u2032-deoxyuridines.","volume":"2","author":"De Clercq E.","year":"1980","unstructured":"De Clercq E. Antiviral and antitumor activities of 5-substituted 2\u2032-deoxyuridines. Methods Find. Exp. Clin. Pharmacol. 2 1980 253 267","journal-title":"Methods Find. Exp. Clin. Pharmacol."},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.28.1.84"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(87)90533-8"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(91)90276-B"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.1980030205"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1080\/15257779408012151"},{"key":"e_1_3_2_30_2","first-page":"19","article-title":"Therapeutic potential of cidofovir (HPMPC, VistideTM) for the treatment of DNA virus (i.e. herpes-, papova-, pox- and adenovirus).","volume":"58","author":"De Clercq E.","year":"1996","unstructured":"De Clercq E. Therapeutic potential of cidofovir (HPMPC, VistideTM) for the treatment of DNA virus (i.e. herpes-, papova-, pox- and adenovirus). Verh. K. Acad. Geneesk. Belg. 58 1996 19 49","journal-title":"Verh. K. Acad. Geneesk. Belg."},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.10.4.674"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1159\/000061700"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1128\/am.16.9.1314-1319.1968"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.3181\/00379727-151-39241"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(75)90502-0"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.200.4341.563"},{"key":"e_1_3_2_37_2","unstructured":"De Clercq E. Descamps J. Torrence P. F. Krajewska E. Shugar D. Antiviral activity of novel deoxyuridine derivatives Current chemotherapy. Proceedings of the 10th International Congress of Chemotherapy Zurich Switzerland 18\u201323 September 1977. Siegenthaler W. L\u00fcthy R. 1978 352 354 American Society for Microbiology Washington D.C."},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/141.5.563"},{"key":"e_1_3_2_39_2","first-page":"321","article-title":"Thymidylate synthetase as target enzyme for the inhibitory activity of 5-substituted 2\u2032-deoxyuridines on mouse leukemia L1210 cell growth.","volume":"19","author":"De Clercq E.","year":"1981","unstructured":"De Clercq E. Balzarini J. Torrence P. F. Mertes M. P. Schmidt C. L. Shugar D. Barr P. J. Jones A. S. Verhelst G. Walker R. T. Thymidylate synthetase as target enzyme for the inhibitory activity of 5-substituted 2\u2032-deoxyuridines on mouse leukemia L1210 cell growth. Mol. Pharmacol. 19 1981 321 330","journal-title":"Mol. Pharmacol."},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/0166-3542(83)90011-6"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/0166-3542(84)90012-3"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm00381a004"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-291X(85)91438-X"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1038\/323464a0"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0166-3542(87)80004-9"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.33.2.185"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(89)90411-5"},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.33.8.1291"},{"key":"e_1_3_2_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(90)90031-F"},{"key":"e_1_3_2_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(91)90120-T"},{"key":"e_1_3_2_51_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.35.4.679"},{"key":"e_1_3_2_52_2","unstructured":"Descamps J. De Clercq E. Broad-spectrum antiviral activity of pyrazofurin (pyrazomycin) Current chemotherapy. Proceedings of the 10th International Congress of Chemotherapy Zurich Switzerland 18\u201323 September 1977. Siegenthaler W. L\u00fcthy R. 1978 354 357 American Society for Microbiology Washington D.C."},{"key":"e_1_3_2_53_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.2.9.878-885.1968"},{"key":"e_1_3_2_54_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00624524"},{"key":"e_1_3_2_55_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm9601314"},{"key":"e_1_3_2_56_2","unstructured":"Fenner F. J. White D. O. Medical virology 1970 190 Academic Press Inc. New York N.Y"},{"key":"e_1_3_2_57_2","unstructured":"Geerinck K. R. Snoeck E. De Clercq and H. Degreef. A case of human orf in an immunocompromised patient successfully treated with cidofovir cream. J. Med. Virol. in press."},{"key":"e_1_3_2_58_2","doi-asserted-by":"crossref","first-page":"305","DOI":"10.4049\/jimmunol.67.4.305","article-title":"Studies on the chemotherapy of vaccinia virus. II. The activity of some thiosemicarbazones.","volume":"67","author":"Hamre D.","year":"1951","unstructured":"Hamre D. Brownlee K. A. Donovick R. Studies on the chemotherapy of vaccinia virus. II. The activity of some thiosemicarbazones. J. Immunol. 67 1951 305 312","journal-title":"J. Immunol."},{"key":"e_1_3_2_59_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.31.11.1849"},{"key":"e_1_3_2_60_2","doi-asserted-by":"publisher","DOI":"10.1177\/095632029300400408"},{"key":"e_1_3_2_61_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid0403.980340"},{"key":"e_1_3_2_62_2","first-page":"197","article-title":"Intracellular metabolism of the antiherpes agent (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine.","volume":"41","author":"Ho H.-T.","year":"1992","unstructured":"Ho H.-T. Woods K. L. Bronson J. J. De Boeck H. Martin J. C. Hitchcock M. J. M. Intracellular metabolism of the antiherpes agent (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine. Mol. Pharmacol. 41 1992 197 202","journal-title":"Mol. Pharmacol."},{"key":"e_1_3_2_63_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm960314q"},{"key":"e_1_3_2_64_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm9811256"},{"key":"e_1_3_2_65_2","doi-asserted-by":"publisher","DOI":"10.1006\/viro.1999.0096"},{"key":"e_1_3_2_66_2","doi-asserted-by":"publisher","DOI":"10.1177\/095632029100200405"},{"key":"e_1_3_2_67_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.72.4.3401-3406.1998"},{"key":"e_1_3_2_68_2","doi-asserted-by":"publisher","DOI":"10.1006\/viro.1997.8735"},{"key":"e_1_3_2_69_2","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-32-2-327"},{"key":"e_1_3_2_70_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.66.3.677"},{"key":"e_1_3_2_71_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.24.3.353"},{"key":"e_1_3_2_72_2","doi-asserted-by":"publisher","DOI":"10.1080\/07328319808003478"},{"key":"e_1_3_2_73_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm960493b"},{"key":"e_1_3_2_74_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm960348y"},{"key":"e_1_3_2_75_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm00117a004"},{"key":"e_1_3_2_76_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1997.03890440061010"},{"key":"e_1_3_2_77_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.2452480"},{"key":"e_1_3_2_78_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.52.1.206-214.1984"},{"key":"e_1_3_2_79_2","unstructured":"Moss B. Poxviridae: the viruses and their replication Fields virology 3rd ed. Fields B. N. Knipe D. M. Howley P. M. 1996 2637 2671 Lippincott-Raven Philadelphia Pa"},{"key":"e_1_3_2_80_2","unstructured":"M\u00fcller W. E. G. Mechanism of action and pharmacology: chemical agents Antiviral agents and viral diseases of man. Galasso G. J. Merigan T. C. Buchanan R. A. 1979 77 149 Raven Press New York N.Y"},{"key":"e_1_3_2_81_2","doi-asserted-by":"publisher","DOI":"10.1177\/095632029700800101"},{"key":"e_1_3_2_82_2","doi-asserted-by":"publisher","DOI":"10.1016\/0166-3542(91)90057-X"},{"key":"e_1_3_2_83_2","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.1890410312"},{"key":"e_1_3_2_84_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.38.12.2710"},{"key":"e_1_3_2_85_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.39.1.56"},{"key":"e_1_3_2_86_2","doi-asserted-by":"publisher","DOI":"10.1124\/mol.53.1.157"},{"key":"e_1_3_2_87_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.45.1.84-87.2001"},{"key":"e_1_3_2_88_2","doi-asserted-by":"publisher","DOI":"10.1021\/jo01269a019"},{"key":"e_1_3_2_89_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm960145"},{"key":"e_1_3_2_90_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm00096a012"},{"key":"e_1_3_2_91_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm00152a016"},{"key":"e_1_3_2_92_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm980163m"},{"key":"e_1_3_2_93_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1099-1654(199709)7:3<145::AID-RMV196>3.0.CO;2-0"},{"key":"e_1_3_2_94_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm00035a010"},{"key":"e_1_3_2_95_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.65.7.3435-3442.1991"},{"key":"e_1_3_2_96_2","doi-asserted-by":"publisher","DOI":"10.1177\/095632029000100402"},{"key":"e_1_3_2_97_2","doi-asserted-by":"publisher","DOI":"10.1006\/viro.1997.8684"},{"key":"e_1_3_2_98_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm00080a018"},{"key":"e_1_3_2_99_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm950853f"},{"key":"e_1_3_2_100_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm00030a014"},{"key":"e_1_3_2_101_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm00035a020"},{"key":"e_1_3_2_102_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm00006a023"},{"key":"e_1_3_2_103_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.177.4050.705"},{"key":"e_1_3_2_104_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.3.2.242"},{"key":"e_1_3_2_105_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0166-3542(00)00105-4"},{"key":"e_1_3_2_106_2","doi-asserted-by":"publisher","DOI":"10.1177\/095632020001100406"},{"key":"e_1_3_2_107_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.68.2.1103-1114.1994"},{"key":"e_1_3_2_108_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.70.4.1174"},{"key":"e_1_3_2_109_2","doi-asserted-by":"publisher","DOI":"10.1038\/222341a0"},{"key":"e_1_3_2_110_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm00127a007"},{"key":"e_1_3_2_111_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm00072a013"},{"key":"e_1_3_2_112_2","first-page":"524","article-title":"Intracellular phosphorylation of broad-spectrum anti-DNA virus agent (S)-9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine and inhibition of viral DNA synthesis.","volume":"32","author":"Votruba I.","year":"1987","unstructured":"Votruba I. Bernaerts R. Sakuma T. De Clercq E. Merta A. Rosenberg I. Hol\u00fd A. Intracellular phosphorylation of broad-spectrum anti-DNA virus agent (S)-9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine and inhibition of viral DNA synthesis. Mol. Pharmacol. 32 1987 524 529","journal-title":"Mol. Pharmacol."},{"key":"e_1_3_2_113_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm00302a025"},{"key":"e_1_3_2_114_2","doi-asserted-by":"publisher","DOI":"10.1177\/095632029400500601"},{"key":"e_1_3_2_115_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm00109a001"},{"key":"e_1_3_2_116_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.54.3.946"},{"key":"e_1_3_2_117_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.41.3.594"},{"key":"e_1_3_2_118_2","first-page":"1109","article-title":"Mechanism of anti-human immunodeficiency virus action of polyoxometalates, a class of broad-spectrum antiviral agents.","volume":"42","author":"Yamamoto N.","year":"1992","unstructured":"Yamamoto N. Schols D. De Clercq E. Debyser Z. Pauwels R. Balzarini J. Nakashima H. Baba M. Hosoya M. Snoeck R. Neyts J. Andrei G. Murrer B. A. Theobald B. Bossard G. Henson G. Abrams M. Picker D. Mechanism of anti-human immunodeficiency virus action of polyoxometalates, a class of broad-spectrum antiviral agents. Mol. Pharmacol. 42 1992 1109 1117","journal-title":"Mol. Pharmacol."}],"container-title":["Clinical Microbiology Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CMR.14.2.382-397.2001","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CMR.14.2.382-397.2001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,23]],"date-time":"2023-04-23T10:48:24Z","timestamp":1682246904000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/CMR.14.2.382-397.2001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,4]]},"references-count":117,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2001,4]]}},"alternative-id":["10.1128\/CMR.14.2.382-397.2001"],"URL":"https:\/\/doi.org\/10.1128\/cmr.14.2.382-397.2001","relation":{},"ISSN":["0893-8512","1098-6618"],"issn-type":[{"value":"0893-8512","type":"print"},{"value":"1098-6618","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,4]]},"assertion":[{"value":"2001-04-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}